BAHA Osseointegrated denied as not medically necessary by Cigna?

Cigna's specific coverage criteria for baha osseointegrated are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denies BAHA (Bone-Anchored Hearing Aid) on Medical-Necessity Grounds

Cigna applies a clinical-criteria framework when reviewing BAHA authorization requests. Medical-necessity denials typically occur because the submitted documentation does not clearly establish: (1) the type and severity of hearing loss, (2) that the patient's hearing-loss type is the specific indication for which BAHA is appropriate (conductive loss, mixed loss, or single-sided deafness), (3) that conventional acoustic hearing-aid candidacy has been adequately evaluated and found insufficient, or (4) that the patient is a suitable surgical candidate for osseointegration. Missing or ambiguous audiometric data is the most common correctable deficiency.

## Why This Denial Is Appealable

Medical-necessity denials for BAHA are routinely overturned when the appeal provides a complete, current audiological workup and a detailed prescriber letter that maps the patient's clinical presentation directly to each criterion in Cigna's published coverage policy. The key is eliminating any gap between what the policy requires and what the submitted record documents.

## Your Federal Appeal Rights

• Internal appeal: ACA §2719 and ERISA §503 guarantee full-and-fair internal review. The denial notice must identify the specific medical-necessity criteria that were not met. File within the deadline stated on the notice.
• External review: Available after a final internal denial. An accredited IRO independently reviews the clinical record against current medical standards. The external-review window is generally approximately four months.
• Expedited review: Available when delay would cause serious or ongoing harm to hearing function or communication ability.

## Documentation to Gather

1. Complete audiological evaluation — a current audiogram (air and bone conduction thresholds) and word-recognition scores from a licensed audiologist, documenting the hearing-loss type and severity in both ears. 2. Conventional hearing-aid evaluation — documentation that the patient was evaluated for conventional acoustic amplification and the clinical reason it is inadequate or contraindicated for this patient's hearing-loss type. 3. Otolaryngologist or surgeon evaluation — a clinical note confirming the diagnosis, surgical candidacy, and the specific indication (conductive, mixed, or single-sided deafness). 4. Prescriber medical-necessity letter — a signed letter from the implanting surgeon mapping the patient's clinical findings to each of Cigna's published coverage criteria, explicitly stating how each criterion is met. 5. Functional-impact documentation — evidence of the impact of untreated hearing loss on daily communication, occupational function, or safety, drawn from the clinical record.

## Criteria-Mapping Structure

Retrieve Cigna's current BAHA coverage policy and list every clinical criterion. For each criterion, write a one-sentence response citing the exact document, date, and finding. Submit this table as the centerpiece of the appeal letter, with the supporting records as labeled attachments referenced by tab number.